These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 10571456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
    Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, Padero M, Mac P, Yarasheski KE, Geurts P, Willemsen A, Harms MK, Bhasin S.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study.
    Mulligan K, Tai VW, Schambelan M.
    J Clin Endocrinol Metab; 1998 May; 83(5):1542-7. PubMed ID: 9589652
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The use of testosterone in the AIDS wasting syndrome.
    Corcoran C, Grinspoon S.
    AIDS Clin Care; 1999 Apr; 11(4):25-6, 33-4. PubMed ID: 11366208
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of selected treatments of HIV wasting: a systematic review and meta-analysis.
    Moyle GJ, Schoelles K, Fahrbach K, Frame D, James K, Scheye R, Cure-Bolt N.
    J Acquir Immune Defic Syndr; 2004 Dec 01; 37 Suppl 5():S262-76. PubMed ID: 15722869
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M, McNurlan M, Freedland E.
    Clin Ther; 2007 Nov 01; 29(11):2269-88. PubMed ID: 18158071
    [Abstract] [Full Text] [Related]

  • 12. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
    Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, Silva de Mendonça J, Falleiros Carvalho LH, Panos G, Pinchera A, Aiuti F, Lee C, Horban A, Gatell J, Phanuphak P, Prasithsirikul W, Gazzard B, Bloch M, Danner SA, E-1696 Study Investigators.
    HIV Med; 2006 Apr 01; 7(3):146-55. PubMed ID: 16494628
    [Abstract] [Full Text] [Related]

  • 13. Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.
    Hengge UR, Stocks K, Faulkner S, Wiehler H, Lorenz C, Jentzen W, Hengge D, Ringham G.
    HIV Clin Trials; 2003 Apr 01; 4(3):150-63. PubMed ID: 12815555
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Approaches to the AIDS Wasting Syndrome.
    Corcoran C.
    Posit Dir News; 1998 Apr 01; 10(2):24-7. PubMed ID: 11365549
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy.
    Moyle GJ, Daar ES, Gertner JM, Kotler DP, Melchior JC, O'brien F, Svanberg E, Serono 9037 Study Team.
    J Acquir Immune Defic Syndr; 2004 Apr 01; 35(4):367-75. PubMed ID: 15097153
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.
    Grinspoon S, Corcoran C, Anderson E, Hubbard J, Stanley T, Basgoz N, Klibanski A.
    Clin Infect Dis; 1999 Mar 01; 28(3):634-6. PubMed ID: 10194091
    [Abstract] [Full Text] [Related]

  • 19. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A.
    J Clin Endocrinol Metab; 1996 Nov 01; 81(11):4051-8. PubMed ID: 8923860
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.